These observations suggest that the timing of metformin administration can potentially substantially influence its efficacy for postprandial glucose-lowering, and that the current recommendation (at least for the immediate-release preparation) that people with type 2 diabetes should take metformin with meals may compromise its benefits
Table 1 Summary of the clinical trials reported in this study
As regulations evolve, platforms operating within existing frameworks may be subject to new compliance requirements
As these sources decline, reduced glucose and insulin levels stimulates free fatty acids mobilisation from adipose tissue
Some premium plans may cover if obesity is linked to a diagnosed comorbidity (diabetes, cardiovascular disease, sleep apnea), but this is the exception, not the rule
doi: 10.1210/mend.14.2.0420